Arax Advisory Partners’s Zymeworks ZYME Stock Holding History

Arax Advisory Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.4K	Buy	+2,998	New	+$76.2K	﹤0.01%	2911
2026 Q1	–	Sell	-169	Closed	-$4.45K	–	4395
2025 Q4	$4.45K	Sell	169 -2,812	-94%	-$61.3K	﹤0.01%	2923
2025 Q3	$50.9K	Buy	+2,981	New	+$42.7K	﹤0.01%	1828
2025 Q1	–	Sell	-169	Closed	-$2.48K	–	3089
2024 Q4	$2.48K	Sell	169 -47	-22%	-$657	﹤0.01%	1959
2024 Q3	$2.71K	Hold	216	–	–	﹤0.01%	1947
2024 Q2	$1.84K	Buy	+216	New	+$1.92K	﹤0.01%	1995

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Arax Advisory Partners's ZYME Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Zymeworks (ZYME) in Q2 2026: 2,998 shares worth $78.4K. The stake represents ﹤0.01% of the portfolio and ranks #2911 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in ZYME as recently as Q4 2025.

Arax Advisory Partners first reported a position in ZYME in Q2 2024 and has held it in 6 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Arax Advisory Partners held 2,998 shares of Zymeworks worth $78.4K as of Q2 2026.
Zymeworks was a new Arax Advisory Partners position in Q2 2026.
Zymeworks made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2911 holding.
Arax Advisory Partners first reported a position in Zymeworks in Q2 2024 and has held it in 6 quarters since.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.